Defining Early Mycosis Fungoides

Total Page:16

File Type:pdf, Size:1020Kb

Defining Early Mycosis Fungoides View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Florence Research Defining early mycosis fungoides Nicola Pimpinelli, MD,a Elise A. Olsen, MD,c Marco Santucci, MD,b Eric Vonderheid, MD,d Andreas C. Haeffner, MD,e Seth Stevens, MD,f Guenter Burg, MD,e Lorenzo Cerroni, MD,g Brigitte Dreno, MD,h Earl Glusac, MD,i Joan Guitart, MD,j PeterW.Heald,MD,i Werner Kempf, MD,e Robert Knobler, MD,k Stuart Lessin, MD,l Christian Sander, MD,m Bruce S. Smoller, MD,n Gladys Telang, MD,o Sean Whittaker, MD,p Keiji Iwatsuki, MD, PhD,q Erik Obitz, MD,r Masahiro Takigawa, MD,s Maria L. Turner, MD,t and Gary S. Wood, MD,u for the International Society for Cutaneous Lymphoma Florence, Italy; Durham, North Carolina; Baltimore, Maryland; Zurich, Switzerland; Thousand Oaks, California; Cleveland, Ohio;GrazandVienna,Austria;Nantes,France; New Haven, Connecticut; Chicago, Illinois; Philadelphia, Pennsylvania; Munich, Germany; Little Rock, Arkansas; Providence, Rhode Island; London, United Kingdom; Okayama and Hamamatsu, Japan; Aarhus, Denmark; Bethesda, Maryland; and Madison, Wisconsin This editorial review summarizes the results of 5 meetings sponsored by the International Society for Cutaneous Lymphoma at which the clinicopathologic and ancillary features of early mycosis fungoides were critically examined. Based on this analysis, an algorithm was developed for the diagnosis of early mycosis fungoides involving a holistic integration of clinical, histopathologic, immunopathologic, and molecular biological characteristics. A novel aspect of this algorithm is that it relies on multiple types of criteria rather than just one, for example, histopathology. Before its finalization, the proposed diagnostic algorithm will require validation and possibly further refinement at multiple centers during the next several years. It is anticipated that a more standardized approach to the diagnosis of early mycosis fungoides will have a beneficial impact on the epidemiology, prognostication, treatment, and analysis of clinical trials pertaining to this most common type of cutaneous lymphoma. ( J Am Acad Dermatol 2005;53:1053-63.) he early diagnosis of mycosis fungoides features with benign dermatoses or discordance (MF), the major subtype of cutaneous T-cell between clinical and pathologic findings. Despite T lymphoma (CTCL), has important ramifica- extensive clinicopathological and investigational tions for therapeutic options, determination of prog- studies of MF and its putative precursors, as well as nosis, and outcomes in clinical trials. However, the strong biases toward particular histologic criteria, diagnosis of MF in its patch or early plaque phase there has been no consensus on the key clinical and is often difficult, either because of overlapping pathologic criteria that would ultimately facilitate From the Department of Dermatological Sciencesa and Depart- Dermatology, Okayama Universityq; Department of Dermatol- ment of Human Pathology and Oncology,b University of ogy, University of Aarhusr; Department of Dermatology, Florence; Division of Dermatology, Duke University, Durhamc; Hamamatsu Universitys; Dermatology Branch, National Cancer Department of Dermatology, Johns Hopkins University, Balti- Institute, Bethesdat; and Department of Dermatology, Univer- mored; Department of Dermatology, University of Zuriche; sity of Wisconsin and Veterans Affairs Medical Center, Amgen, Inc, Thousand Oaksf; Department of Dermatology, Madison.u University of Grazg; Department of Dermatology, CHU Nantesh; Funding sources: Research funding provided by the Department Department of Dermatology, Yale University, New Haveni; De- of Veterans Affairs and National Institutes of Health grant AR-02136 partment of Dermatology, Northwestern University, Chicagoj; (to G. S. W.). Division of Special and Environmental Dermatology, Medical Conflicts of interest: None identified. University of Viennak; Division of Dermatology, Fox Chase Parts of this work have been presented at international meetings. Cancer Center, Philadelphial; Department of Dermatology, Reprint requests: Gary S. Wood, MD, Department of Dermatology, University of Munichm; Department of Pathology, University University of Wisconsin, One South Park, 7th Floor, Madison, of Arkansas, Little Rockn; Department of Dermatology, Brown WI 53715. E-mail: [email protected]. University, Providenceo; St John’s Institute of Dermatology, 0190-9622/$30.00 guys and St Thomas’ Hospital NHS Trust, Skin Cancer Unit, ª 2005 by the American Academy of Dermatology, Inc. Division of Skin Sciences KCL, Londonp; Department of doi:10.1016/j.jaad.2005.08.057 1053 1054 Pimpinelli et al JAM ACAD DERMATOL DECEMBER 2005 dermatosis that was part of a larger spectrum of Abbreviations used: eczematoid, psoriasiform, or lichenoid skin disor- CI: confidence interval ders (‘‘les parapsoriasis’’) whose nosology has been CTCL: cutaneous T-cell lymphoma reviewed elsewhere.2 The relation between PEP and DGGE: denaturing gradient gel electrophoresis 3 ISCL: International Society for Cutaneous MF was first specifically addressed by Civatte Lymphoma (Brocq’s disciple) and other groups, including those MF: mycosis fungoides of Osmundsen,4 Samman,5 Bonvalet et al,6 and OR: odds ratio 7 PCR: polymerase chain reaction Binazzi who made careful clinicopathologic cor- PEP: parapsoriasis en plaques relations from series of patients with PEP followed over time. A ‘‘small’’ lesion variant, now commonly termed small-plaque parapsoriasis, was distin- collaborative multicenter research studies of early guished from a ‘‘large’’ lesion variant, now referred disease. to as large plaque parapsoriasis, on the basis of size, Recognizing this persistent need to develop preferential distribution of lesions, and the presence standardized diagnostic criteria for early MF, the or absence of atrophy and/or poikiloderma.2 The International Society for Cutaneous Lymphoma skin lesions of both small-plaque parapsoriasis and (ISCL) sponsored meetings in Zurich, Switzerland large-plaque parapsoriasis are flat patches rather on May 28-31, 1999; in Napa, California on March 9, than infiltrated plaques, consistent with the fact that 2000; in Bethesda, Maryland on March 1, 2001; in the French term plaque equates to the English term New Orleans, Louisiana on Feb 21, 2002; and in patch. Therefore these two conditions would be Washington, DC on Feb 5, 2004 with the following termed most appropriately ‘‘small-patch parapsoria- goals: (1) to facilitate discussion on this topic among sis’’ and ‘‘large-patch parapsoriasis,’’ except that these clinicians and scientists with extensive experience terms incorporating the word ‘‘plaque’’ are embed- in CTCL; (2) to develop a working proposal for ded in the literature.8,9 diagnostic criteria for early MF, taking into account The lesions of small-plaque parapsoriasis are clinical, histologic, and ancillary (particularly immu- generally on the upper trunk, sometimes with a nophenotypic and genotypic) criteria; and (3) to test digitate appearance (so-called ‘‘digitate dermatosis’’) the validity of these criteria in an international and without atrophy or poikiloderma.2 Lesions are collaborative forum. We are confident that meeting usually 2 to 6 cm in diameter; however, the long axis these goals will help to better evaluate the true of digitate lesions may be up to 10 to 20 cm, imparting incidence of MF, to potentially discriminate among a ‘‘fingermark’’ appearance. Histologically, small- prognostic subsets of MF, to advance the under- plaque parapsoriasis has been characterized by standing of factors involved in the pathogenesis of nonspecific changes (focal spongiotic and/or psori- MF and its progression, and to aid in the development asiform and/or lichenoid dermatitis with exocytosis of differential therapeutic approaches likely to im- of small lymphocytes). Small-plaque parapsoriasis prove current remission and survival rates. The has been judged to have little, if any, potential to meetings noted above accomplished the first goal. evolve to typical MF.8 This article summarizing the meetings’ proceedings In contrast, the lesions of large-plaque parapsori- addresses the second goal and creates a framework asis are usually larger than 6 cm in diameter and for achieving the third objective through future col- localized to the buttocks, lower trunk, upper thighs, laborative studies. inner upper arms, and inframammary areas (ie, non- sun-exposed regions) and frequently manifest atro- phy and/or poikiloderma. Histologically, the pattern RELATIONSHIP BETWEEN MF AND of lymphoid infiltration in large-plaque parapsori- PARAPSORIASIS EN PLAQUES: asis is similar to small-plaque parapsoriasis, but the HISTORICAL PERSPECTIVE AND infiltrates often contain lymphocytes with cerebri- CURRENT IMPLICATIONS form nuclei called Lutzner cells (synonymous with Part of the difficulty in establishing threshold Se´zary cells) similar to that seen in MF. Large-plaque criteria for the diagnosis of early MF stems from the parapsoriasis has been long regarded to be difficult existence of established terminology for reputedly to distinguish from patch-phase MF, with progres- benign dermatoses, such as parapsoriasis en plaques sion to frank MF in 7.5% to 14% of cases.2,5-7 (PEP), that have overlapping clinical and/or histo- In 1979, Sanchez and Ackerman10 suggested that logic features with early MF. By utilizing clinical instead of large-plaque psoriasis evolving into frank findings only, PEP was defined by Brocq1 in 1902 MF only in selected cases,
Recommended publications
  • Approach to Pediatric Psoriasis”, a Podcast Made for Pedscases.Com at the University of Alberta
    Welcome to “Approach to Pediatric Psoriasis”, a podcast made for PedsCases.com at the University of Alberta. I am Dr. Harry Liu, a dermatology resident at the University of British Columbia, and I am David Jung, a medical student at the University of British Columbia. This podcast will provide an organized approach to understand pediatric psoriasis, a common dermatological condition in pediatric population. We would like to thank Dr. Joseph Lam, a pediatric dermatologist practicing in Vancouver, BC, Canada, for developing this podcast with us! 1 After listening to this podcast, we expect the learner to be able to: 1. Describe the typical clinical presentations of psoriasis 2. Discuss the underlying pathophysiology of psoriasis 3. Identify different types of psoriasis and their unique characteristics 4. Recall epidemiological risk factors and comorbidities associated with psoriasis 5. List common treatment options for pediatric psoriasis 2 First, we’d like to present a case. It is your day at an urban pediatric clinic as a fourth- year elective student. Your first patient is Lucy, an 8-year-old girl brought in by her mother for the concern of a newly developed rash. On history, Lucy has had the rash on her knees for about 3 months. The rash has gradually increased in size and has become quite scaly. When Lucy scratches, her mother also notices some bleeding. The mother is quite concerned because the rash has made many kids at school avoid Lucy. Before the development of the rash, Lucy had an episode of culture proven group A Streptococcal (GAS) pharyngitis which resolved with oral antibiotics; she is otherwise very healthy.
    [Show full text]
  • History of Psoriasis and Parapsoriasis
    History of Psoriasis and Parapsoriasis By Karl Holubar Summary Parapsoriasis is «oï a disease entity. Jt is an auxiliary term introduced in J 902 to group several dermatoses w>itk a/aint similarity to psoriasis. Tlie liistorical development leading to tlie creation o/ t/ie term parapsoriasis is outlined and t/te Itistory o/psoriasis is 6rie/ly reviewed. Semantic and terminological considerations Obviously, para-psoriasis as a term has been created in analogy to psoriasis. We should remember similar neologisms in medical language, e. g. protein and para-protein; typhoid and para-typhoid, thyroid and para-thyroid, phimosis and para-phimosis, eventually, pemphigus and para-pemphigus (the latter in 1955 this term was to be employed instead of pemphigoid but was not accepted by the dermatological world). Literally, para is a Greek preposition, (with the genitive, dative and accusative), meaning: by the side of, next to something, alongside something. In medicine, para is used often as a prefix to another term, which designates a condition somewhat similar to the one under consideration. The same holds for psoriasis and parapsoria- sis. In detail, though, it is a bit more complicated. Parapsoriasis has more than one "/at/ier", three in fact: ideiurick /Iu.spitz f 1835—1886,), Paul Gerson Luna (A850—1929j and Louis Procç fI856—I928J. Auspitz, in 1881, had published a new system of skin diseases the seventh class of which was called epidermidoses, subdivided into liypcrlcfiratose.s, parakeratoses, kerato/y- ses, the characteristics of which were excessive keratinization, abnormal keratinization and insufficent keratinization. When Unna, in 1890®, pub- lished his two reports on what he called parakeratosis variegata, he referred to Auspitz' system and term when coining his own.
    [Show full text]
  • “I Have a Rash!”
    “I have a rash!” Kim Sanders PA-C Assistant Professor OHSU Dermatology Disclosures • none Goals: • Compare and contrast some common dermatological conditions • Present some less common conditions that are mimickers of common conditions Case #1: • 25 year old healthy female with a new rash x 4 weeks. • It is mildly itchy and covers most of her trunk • She is feeling well currently, but notes a cold and sore throat prior to the eruption of the rash that has resolved without treatment • She recently started a new job that includes public speaking. Due to her anxiety over this she has started prn propranolol. • No other medications or chronic medical conditions • Family history significant for an uncle that had “skin problems”, no details known • Social history: she is single and actively dating. Does admit to recent unprotected intercourse with more than one male partner. Clinical exam: Differential diagnosis: • Guttate psoriasis • Syphilis • Pityriasis rosea • Extensive tinea corporis A little more history… • She does feel that the rash started with one plaque on her right anterior hip about a week before it exploded all over her body Diagnosis: • Pityriasis rosea! • Should you get an RPR? Treatment: • Topical steroids if needed to help with itching • Consider biopsy if does not resolve within 12 weeks Considerations: • What if she had strep throat prior to the eruption of the rash? • What if she had erythematous macules on her palms? • What if you saw her the first week, when she only had one lesion? • Is the addition of propranolol important? Case #2 • 40 year old female with new onset hair loss first noticed by her hair dresser, however it is progressing quickly.
    [Show full text]
  • Pediatric Psoriasis
    Pediatric Papulosquamous and Eczematous Disorders St. John’s Episcopal Hospital Program Director- Dr. Suzanne Sirota-Rozenberg Dr. Brett Dolgin, DO Dr. Asma Ahmed, DO Dr. Anna Slobodskya, DO Dr. Stephanie Lasky, DO Dr. Louis Siegel, DO Dr. Evelyn Gordon, DO Dr. Vanita Chand, DO Pediatric Psoriasis Epidemiology • Psoriasis can first appear at any age, from infancy to the eighth decade of life • The prevalence of psoriasis in children ages 0 to 18 years old is 1% with an incidence of 40.8 per 100,000 ppl • ~ 75% have onset before 40 years of age What causes psoriasis? • Multifactorial • Genetics – HLA associations (Cw6, B13, B17, B57, B27, DR7) • Abnormal T cell activation – Th1, Th17 with increased cytokines IL 1, 2, 12, 17, 23, IFN-gamma, TNF-alpha • External triggers: – Injury (Koebner phenomenon) – medications (lithium, IFNs, β-blockers, antimalarials, rapid taper of systemic corticosteroids) – infections (particularly streptococcal tonsillitis). Pediatric Psoriasis Types: • Acute Guttate Psoriasis – Small erythematous plaques occurring after infection (MOST common in children) • 40% of patients with guttate psoriasis will progress to develop plaque type psoriasis • Chronic plaque Psoriasis – erythematous plaques with scaling • Flexural Psoriasis – Erythematous areas between skin folds • Scalp Psoriasis – Thick scale found on scalp • Nail Psoriasis – Nail dystrophy • Erythrodermic Psoriasis– Severe erythema covering all or most of the body • Pustular Psoriasis – Acutely arising pustules • Photosensitive Psoriasis – Seen in areas of sun
    [Show full text]
  • The Conundrum of Parapsoriasis Versus Patch Stage of Mycosis Fungoides
    View TThehe cconundrumonundrum ofof parapsoriasisparapsoriasis versusversus patchpatch stagestage Point ooff mmycosisycosis ffungoidesungoides KK.. NN.. SSarveswari,arveswari, PPatrickatrick YYesudianesudian Sundaram Medical Foundation, ABSTRACT Dr. Rangarajan Memorial Hospital, Chennai, Tamilnadu, Terminological confusion with benign dermatosis, such as parapsoriasis en plaques, makes India it difÞ cult to diagnose mycosis fungoides in the early patch stage. Early diagnosis of mycosis fungoides (MF) is important for deciding on type of therapy, prognosis and for further follow-up. Address for correspondence: Dr. K. N. Sarveswari, However, until recently, there has been no consensus on criteria that would help in diagnosing Sundaram Medical the disease early. Some believe that large plaque parapsoriasis (LPP) should be classiÞ ed Foundation, Dr. Rangarajan with early patch stage of MF and should be treated aggressively. However, there is no Þ rm Memorial Hospital, Shanthi clinical or laboratory criteria to predict which LPP will progress to MF and we can only discuss Colony - IV Avenue, Anna about statistical probability. Moreover, long-term outcome analysis of even patch stage of MF Nagar, Chennai - 600 040, Tamilnadu, India. is similar to that of control population. We therefore believe that LPP should be considered E-mail: sarveswari@ as a separate entity at least to prevent the patient from being given a frightening diagnosis. smfhospital.org We also feel that patients need not be treated with aggressive therapy for LPP and will need
    [Show full text]
  • Pityriasis Lichenoides Devang G
    pediatric dermatology Pityriasis Lichenoides Devang G. Patel, MD George Kihiczak, MD Robert A. Schwartz, MD, MPH Camila K. Janniger, MD W. Clark Lambert, MD, PhD Pityriasis lichenoides (PL) is a skin disorder of un- PL from small and large plaque parapsoriasis, includ- known etiology that mainly affects children and young ing digitate dermatosis, xanthoerythrodermia perstans, adults. Pityriasis lichenoides is perhaps best considered and the rare entity, retiform parapsoriasis. a disease spectrum with acute and chronic types: pityr- iasis lichenoides et varioliformis acuta (PLEVA) and Incidence pityriasis lichenoides chronica (PLC). Pityriasis Pityriasis lichenoides most commonly occurs in chil- lichenoides et varioliformis acuta, the acute variant, is dren and young adults; however, its precise incidence characterized by the onset of papulovesicular eruptions is unknown. Both PLC and PLEVA appear to be that evolve into necrotic lesions over the trunk and about as common in males as in females, with PLC extremities, and hence the name “varioliformis,” occurring more frequently. Pityriasis lichenoides et which means “like variola” (like smallpox). Pityriasis varioliformis acuta most often occurs during the sec- lichenoides chronica, the chronic form, involves re- ond or third decade of life. However, the disease may current crops of papules that may last from several also arise in children and the elderly, and may even months to several years. Both types are further char- be evident at birth.10 There is no apparent racial or acterized by independent evolution of each lesion, so geographic predisposition.1,2 that lesions in all different states of progression are found next to each other in a random array.
    [Show full text]
  • Erythroderma Due to Pityriasis Rubra Pilaris
    International Journal of Pathology; 2005; 3(2): 91-93 Case Report Erythroderma Due to Pityriasis Rubra Pilaris Ikramullah Khan and Uzma Khalil Department of Dermatology, Pakistan Institute of Medical Sciences, Islamabad Erythroderma can be due to a number of causes. Pityriasis Rubra Pilaris contributing to 1% of all the cases. Pityriasis Rubra Pilaris belongs to a rare erythematosquamous disorders of unknown etiology. We report here a case of Pityriasis Rubra Pilaris that progressed to erythroderma. Key words: pityriasis rubra pilaaris, PRP, HIV human immunodeficiency virus HAART, highly active anti retroviral therapy Introduction and toe nails were shiny. Erythroderma is generalized erythema of Nails were thickened and yellowish in colour skin affecting over 90% of body surface area. It with splinter hemorrhages and whitish longitudinal can be due to several causes. Pityriasis rubra pilaris bands. There was also subungual hyperkeratosis.. contributes to one percent of all cases of erythroderma. Palms and soles were hyperkeratotic named as PRP Pityriasis rubra pilaris is a heterogenous group of sandals. Usually PRP is associated with HIV infection disorders that have circumscribed follicular keratosis, but our patient was negative for it. brauny skin and orange red erythema. This is A skin biopsy taken from arm showed a rare disease with an incidence of one in 50001. It hyperkeratosis, parafollicular parakeratosis, follicular has a world wide distribution.15 It is one of the plugging, prominent granular layer (Figure 4 & 5). papulo squamous disorders that runs a chronic Dermis showed mild capillary dilatation and mild relapsing course.5,13 lymphohistiocytic infilterate. Some eosinophils were We report a case of pityriasis rubra also noted.
    [Show full text]
  • Pityriasis Lichenoides-Like Drug Reaction
    Volume 23 Number 11 | November 2017 Dermatology Online Journal || Case Report 23 (11): 2 Pityriasis lichenoides-like drug reaction: A clinical histopathologic study of 10 cases Cynthia Magro1 MD, Ruifeng Guo2 MD PhD, Giang Huong Nguyen3 MD PhD, Hamilton Tsang4 MD, Shabnam Momtahen5 MD Affiliations: 1Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, 2University of Florida Health Pathology Laboratories, Gainesville, Florida, 3Department of Dermatology, University of Colorado, Aurora, Colorado, 4Department of Laboratory Medicine, University of Washington, Seattle, Washington, 5Department of Pathology, Dartmouth- Hitchcock Medical Center, Lebanon, New Hampshire Corresponding Author: Cynthia M. Magro M.D., Professor of Pathology and Laboratory Medicine, Professor of Dermatopathology in Dermatology, Director of Dermatopathology, Weill Cornell Medicine, Department of Pathology & Laboratory Medicine, 1300 York Avenue, F-309, New York, NY 10065, Tel: 212-746-6434, Fax: 212-746-8570, Email: [email protected] Abstract Introduction Cutaneous drug eruptions define a common Background: Lymphomatoid drug reactions can mimic adverse effect of drug therapy [1-5]. Although most endogenous T and B cell lymphoproliferative diseases. drug eruptions are mild, life-threatening reactions Objectives: We present a novel form of cutaneous are common. These include Stevens-Johnson drug reaction with features of pityriasis lichenoides syndrome, toxic epidermal necrolysis, erythroderma, (PL), a recognized form of T cell dyscrasia. Methods: and angioedema [6-9]. Most drug eruptions Ten cases were studied where a cutaneous eruption are immunologically mediated, although non- exhibiting semblance to PL within a few weeks to immunological drug eruptions are known to occur months after starting a particular drug. Results: The [10].
    [Show full text]
  • Parapsoriasis Small-Plaque =نظير الصدف صغير اللويحات
    اﻠﻠوﻴﺤاﺖ ﺻﻐﻴﺮ اﻠﺼدﻒ ﻧﻈﻴﺮ= Parapsoriasis Small-plaque Parapsoriasis 1 / 18 اﻠﻠوﻴﺤاﺖ ﺻﻐﻴﺮ اﻠﺼدﻒ ﻧﻈﻴﺮ= Parapsoriasis Small-plaque Historical Aspects the currently accepted classification of parapsoriasis includes large and small-plaque forms of parapsoriasis en plaques (often referred to simply as parapsoriasis) as well as acute and chronic forms of pityriasis lichenoides [known today as pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC), respectively].1 Pityriasis lichenoides was first described in 1894 by Neisser 7 and Jadassohn. 8 In 1899 Juliusberg delineated the chronic form and named it PLC.Mucha redescribed the acute form in 1916 and distinguished it from the chronic form. Habermann named the acute variant PLEVA in 1925. Mucha-Habermann disease is synonymous with PLEVA. Some authors regard lymphomatoid papulosis as a variant of pityriasis lichenoides, whereas others consider it to be a separate disease. Lymphomatoid papulosis is discussed in Chap. 146 as part of the spectrum of CD30 + cutaneous lymphoproliferative disorders. Classification of Parapsoriasis 1. Parapsoriasis en plaques 1. Large-plaque parapsoriasis Variants: poikilodermatous, retiform 2. Small-plaque parapsoriasis Variant: digitate dermatosis 3. Pityriasis lichenoides 1. Pityriasis lichenoides chronica (Juliusberg) 2. Pityriasis lichenoides et varioliformis acuta (Mucha-Habermann) 2 / 18 اﻠﻠوﻴﺤاﺖ ﺻﻐﻴﺮ اﻠﺼدﻒ ﻧﻈﻴﺮ= Parapsoriasis Small-plaque Epidemiology Large-plaque parapsoriasis (LPP) and small-plaque parapsoriasis (SPP) are, in general, diseases of middle-aged and older people, with a peak incidence in the fifth decade. Occasionally, lesions arise in childhood and may be associated with pityriasis lichenoides. SPP shows a definite male predominance of approximately 3:1. LPP is probably more common in males, but the difference is not as striking as in SPP.
    [Show full text]
  • Infantile Psoriasis
    PEDIATRIC DERMATOLOGY Series Editor: Camila K. Janniger, MD Infantile Psoriasis Camila K. Janniger, MD; Robert A. Schwartz, MD, MPH; Maria Letizia Musumeci, MD, PhD; Aurora Tedeschi, MD; Barbara Mirona, MD; Giuseppe Micali, MD Psoriasis is a common inherited papulosqua- several chromosomes at which putative psoriasis mous dermatosis that may be a diagnostic genes may be located. Disease susceptibility genes dilemma, particularly in infants and children. The are thought to be present on chromosomes 4q, 6p, treatment of children with psoriasis should be 16q, and 20p. Moreover, on chromosome 1q, genes handled with caution and tailored according to regulating epidermal differentiation have been iden- the child’s age, as well as to the extent, distribu- tified. Linkage to this area has been proposed. tion, and type of psoriasis. Furthermore, psoriasis gene loci on chromosomes 2, Cutis. 2005;76:173-177. 8, and 20 have been suggested.12 Physical injury to the skin (Köbner phe- soriasis is a common inherited papulosquamous nomenon), low humidity,5 cold weather, and stress dermatosis that often represents a diagnostic may represent important triggering factors.9 Worsen- P dilemma in infants.1-3 The diagnosis may be ing of psoriasis following stress was observed in 50% challenging if the disease is mild or if the presenta- of 223 pediatric patients in one survey and in 90% tion is atypical.4 of 245 children in another.9,13 In addition, in young children, viral or bacterial infection (particularly Pathogenesis due to Streptococcus) may be a common initiating Both genetic and environmental factors interact to and maintaining factor, especially for the develop- precipitate the development of psoriasis.5 A family ment of acute guttate psoriasis.14,15 history of psoriasis is seen in 25% to 71% of patients In childhood, psoriasis may be induced by some with the disease.2,6-9 Generally, an earlier onset of medications, the most common being antimalarials the disease correlates with familial frequency7; the and systemic corticosteroids.
    [Show full text]
  • R J M E RIGINAL APER Romanian Journal of O P Morphology & Embryology
    Rom J Morphol Embryol 2014, 55(3 Suppl):1085–1092 R J M E RIGINAL APER Romanian Journal of O P Morphology & Embryology http://www.rjme.ro/ Biopsying parapsoriasis: quo vadis? Are morphological stains enough or are ancillary tests needed? FLAVIA BADERCA1,2), ELENA CHITICARIU3), MICHAEL BAUDIS4), CAIUS SOLOVAN5,6) 1)Department of Microscopic Morphology, “Victor Babeş” University of Medicine and Pharmacy, Timisoara, Romania 2)Service of Pathology, Emergency City Hospital, Timisoara, Romania 3)PhD Student, “Victor Babeş” University of Medicine and Pharmacy, Timisoara, Romania 4)Institute of Molecular Life Sciences, University of Zurich, Switzerland 5)Department of Dermatology, “Victor Babeş” University of Medicine and Pharmacy, Timisoara, Romania 6)Department of Dermatology, Emergency City Hospital, Timisoara, Romania Abstract Background: Parapsoriasis represents a group of cutaneous disorders that shows variable clinical aspects somehow resembling to psoriasis, how is reflecting by its name. It was first named by Brocq, in 1902, as an entity with three components: pityriasis lichenoides, small plaque parapsoriasis and large plaque parapsoriasis. Nowadays, under the name of parapsoriasis are included only the last two categories, that are considered disorders characterized by the presence of a mononuclear infiltrate in the dermis, composed of T-cells. Until now, there were not established pathognomonic histopathological features to diagnose parapsoriasis. Aim: The aim of the study was to investigate the epidemiological and morphological data of parapsoriasis cases diagnosed at Emergency City Hospital, Timisoara, Romania for a period of 12 years. Materials and Methods: The study had two parts; one was retrospective and another one prospective. For the retrospective part, we searched 210111 patient files recorded in our Pathology Service for a period of 11 years, from January 2002 to December 2012.
    [Show full text]
  • Pityriasis Lichenoides Chronica Presenting with Bilateral Palmoplantar Involvement
    Pityriasis Lichenoides Chronica Presenting With Bilateral Palmoplantar Involvement Lyubov Avshalumova, DO; Blakely Richardson, DO; Richard Miller, DO PRACTICE POINTS • Diagnosis of pityriasis lichenoides may be difficult due to a wide spectrum of clinical presentations. • Pityriasis lichenoides chronica (PLC) with palmoplantar involvement may mimic psoriasis. • Screening for infections is not recommended in patients with PLC unless the patient has other symptoms pointing to a specific infection. • Phototherapy currently is the most effective treatment modality for PLC.copy not Pityriasis lichenoides is an uncommon, acquired, pityriasis lichenoides et varioliformis acuta (PLEVA), idiopathic, self-limiting skin disease that poses a pityriasis lichenoides chronica (PLC), and febrile challenge to patients and clinicians to diagnose ulceronecrotic Mucha-Habermann disease. Precise and treat. Several variants exist including pityriasisDo classification can be difficult due to an overlap of lichenoides et varioliformis acuta (PLEVA), pityria- clinical and histologic features. The spectrum of sis lichenoides chronica (PLC), and febrile ulcer- this inflammatory skin disorder is characterized by onecrotic Mucha-Habermann disease. Precise recurrent crops of spontaneously regressing papulo- classification can be difficult due to an overlap of squamous, polymorphic, and ulceronecrotic papules clinical and histologic features. In this case report affecting the trunk and extremities. Pityriasis lichen- we describe a patient with a rare presentation of oides is a monoclonal T-cell disorder that needs care- PLC exhibiting bilateral palmoplantar involvement ful follow-up because it can progress, though rarely, and mimicking psoriasis. CUTISWe review the literature to cutaneous T-cell lymphoma. In this case report we and discuss the clinical course, pathogenesis, and describe a patient with a rare presentation of PLC current treatment modalities of PLC.
    [Show full text]